If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Execution of Cambay SPA

10 Jun 2021 12:05

RNS Number : 5179B
Oilex Ltd
10 June 2021
 

 

ASX-RNS Announcement

 

 

10 June 2021

 

ASX: OEX

AIM: OEX

Execution of Cambay SPA

 

Oilex Ltd (the Company) is pleased to announce that, further to recent announcements, the conditional binding sale and purchase agreement to acquire GSPC's 55% participating interest (PI) in the Cambay Production Sharing Contract (Cambay) (the Acquisition) has now been executed by both parties.

 

The ratification of the Acquisition by the Government of India is expected to occur in the coming months, which is the last outstanding condition to completion of the Acquisition Following completion of the previously announced equity raise, and shareholder approval provided on 8 June 2021, Oilex is currently securing a bank guarantee for the US$2.2 million consideration payable for the Acquisition.

 

The Acquisition will provide Oilex with 100% PI in the Cambay PSC. The primary interest in the PSC is the proven gas accumulation in the EP-IV tight siltstone reservoir, which has been produced historically by the Company at low rates from a number of wells within the PSC. Oilex has undertaken extensive technical studies on the asset and the Company's drilling plans in relation to a pilot program are well advanced, subject to finalisation of funding alternatives, with the aim of establishing flow rates after hydraulic stimulation of the Eocene siltstone reservoir.

 

The pilot program will implement the recommendations from a 2017/18 Baker Hughes-GE study focussed on drilling and stimulation using world-wide best practice. Any initial hydrocarbon production from these wells will utilise the existing Cambay processing and storage facilities and the connection to a local low pressure gas pipeline. Given success, the production facilities will be upgraded on an as required basis to provide a low-cost path to commercialise increased gas flows resulting from additional production wells.

 

The ultimate project aim is to aggregate sufficient production volumes from multiple wells to connect to the high-pressure pipeline system which will offer greater offtake stability and improved gas prices. It is anticipated that the results of the pilot program will provide the necessary data to determine whether horizontal wells can deliver an estimated 3 to 5 fold increase on well productivity, thereby offering the highest commercial returns for the project in order to exploit the third party gross contingent resource estimate of 926 BCF of gas and 61 million barrels of condensate (RISC 2015).

 

Oilex's Managing Director, Mr Joe Salomon, said:

 

"Finalisation of this transaction marks an important milestone in re-establishing access to high potential gas production at the Cambay gas field and positions the Oilex, once more, as an active Indian energy company. Oilex remains one of the few international companies active in the sector in India where we see enormous potential both for gas projects as well as renewable energy and carbon abatement projects. During the next few months, we will determine the Company's optimal participation level in the project and re-commence operational activities. Over the past few years, we have continued to review additional projects while also continuing to progress our UK assets. As a result, from this stronger platform we see opportunities to build on Oilex's current project inventory. I would like to take this opportunity to thank our staff and stakeholders who have maintained support for the Company as it has navigated these challenges."

 

 

 

For and on behalf of Oilex Ltd

 

 

Joe Salomon

Managing Director

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Consulting

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigoconsulting.com

chris.mcmahon@vvigoconsulting.com

Tel:+ 44 20 7390 0230 UK

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDKKBKDBKDQAD
Date   Source Headline
14th May 20217:00 amRNSIssue of Securities and Appendix 2A
7th May 20217:00 amRNSNotice of General Meeting
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 20219:55 amRNSChange of Interests of Substantial Holder
30th Apr 20217:36 amRNSMarch 2021 Quarterly Report
29th Apr 202111:06 amRNSIssue of Securities
23rd Apr 202110:24 amRNSIssue of Securities
23rd Apr 20217:00 amRNSInd Govt approval of Cambay PSC Work Prog/Budget
21st Apr 20211:43 pmRNSAcquisition Funding Arranged
13th Apr 20217:00 amRNSBhandut PSC PI Sale Finalisation
7th Apr 20215:51 pmRNSIssue of Securities
6th Apr 202111:00 amRNSPrice Monitoring Extension
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
1st Apr 20219:32 amRNSUpdate Regarding Cambay Settlement
17th Mar 20217:00 amRNSAppendix 2A
16th Mar 20217:00 amRNSCorrection: Equity Issue
15th Mar 20217:19 amRNSHalf Year Accounts
15th Mar 20217:00 amRNSSeries D Loan Restructure and Equity Issue
17th Feb 20217:00 amRNSAppendix 3Y P Schwarz
17th Feb 20217:00 amRNSAppendix 3Y P Haywood
15th Feb 20217:59 amRNSUpdate on proposal to acq interest in Cambay PSC
15th Feb 20217:46 amRNSTrading Halt Request
12th Feb 20218:15 amRNSIssue of Securities and Appendix 2A
1st Feb 20217:00 amRNSDecember 2020 Quarterly Report
24th Dec 20207:00 amRNSSeries C Loan Extension
17th Dec 202011:20 amRNSExecutive Directors Contract Extensions
17th Dec 202010:51 amRNSIssue of Securities
16th Dec 20207:00 amRNSResults of Annual General Meeting
14th Dec 20207:00 amRNSCompletion of East Irish Sea Transaction P2446
16th Nov 20207:00 amRNS2020 Notice of Annual General Meeting
6th Nov 20207:55 amRNSCorrection Waiver Granted
5th Nov 20207:30 amRNSWaiver Granted
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Financial Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Announcement
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Chairmans Review
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Directors Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Business Review
30th Oct 20209:54 amRNSSeptember 2020 Quarterly Report
30th Oct 20209:37 amRNSSeries C Loan Restructure
15th Oct 20208:54 amRNSArmour Completion and Update on Projects
1st Oct 20207:08 amRNSAppendix 4G
1st Oct 20207:00 amRNSCorporate Governance Statement 2020
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Financial Report
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Directors Report
1st Oct 20207:00 amRNSUnaudited Annual Report 2020 - Announcement
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Business Review
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report -Chairmans Review
14th Sep 202012:17 pmRNSArmour Share Purchase Agreement – Update
10th Aug 20207:00 amRNSIssue of Securities and Appendix 2A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.